Dividend policy issues in the European pharmaceutical industry : new empirical evidence
Year of publication: |
2023
|
---|---|
Authors: | Basse, Tobias ; Schwarzbach, Christoph ; Schulenburg, Johann-Matthias von der |
Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 24.2023, 5, p. 803-816
|
Subject: | Dividend policy | Granger causality | Health care firms | Litigation risk | Pharmaceutical industry | Research and development expenditures | Pharmaindustrie | Industrieforschung | Industrial research | Dividende | Dividend | EU-Staaten | EU countries | Gesundheitskosten | Health care costs | Kausalanalyse | Causality analysis |
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2017)
-
Lu, Z. John, (2020)
-
The relationship between capital investment and R&D spending : a panel cointegration analysis
De Jong, Pieter J., (2007)
- More ...
-
Kapitalanlagen und ihr Rating - die Assekuranz zwischen Regulierung und Niedrigzinsphase
Gonzalez, Miguel Rodriguez, (2016)
-
Linderkamp, Tim, (2015)
-
Investmentalternativen für die Versicherungswirtschaft
Gonzalez, Miguel Rodriguez, (2018)
- More ...